Skip to main content
. 2015 Dec 14;5:18001. doi: 10.1038/srep18001

Figure 4. Variations of IL-23 concentrations in BP serum from baseline until day 60 according to later BP relapse.

Figure 4

Serum concentrations of IL-23 were measured by ELISA at time of diagnosis and at day 60 in patients in remission (a) and patients who later relapsed (b). The group of patients who further relapsed was divided into 2 subgroups according to IL-23 concentrations at diagnosis: in serum in which IL-23 was undetectable at time of diagnosis (c), and in serum in which IL-23 was detectable at diagnosis (d). (**P < 0.01; ***P < 0.001)